Samedan Ltd Pharmaceutical Publishers


Advanced search

Buy Valtrex Online Buy Cipro without prescription\|Yaz online no prescription \|Buy Clomid no prescription\|Buy Alesse online no prescription\|Buy Armour without prescription\|Buy Dexamethasone without prescription\|Buy Colchicine without prescription \|Buy Prednisolone without prescription\|Buy Synthroid no prescription Buy Mirapex without prescription \|Buy Lamictal no prescription\|Buy Atenolol without prescription Publications European Pharmaceutical Contractor European Biopharmaceutical Review International Clinical Trials Pharmaceutical Manufacturing and Packing Sourcer Innovations in Pharmaceutical Technology Subscribe Online White Papers Samedan app Pharmaceutical Directory Industry Events Calendar News and Press Releases Employment Opportunities Advertising with us Contact Us

home > ict

PUBLICATIONS

International Clinical Trials

International Clinical Trials (ICT) is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector.

Published quarterly, and edited by Dr Graham Hughes, the journal offers a platform of communication and information-sharing for executive and strategic decision-makers, seeking out new trends and marketing opportunities, as well as putting a spotlight on the latest innovations coming to market. ICT is specifically designed to be of interest to those actively seeking to source services for improved efficiency in what is an increasingly competitive market.

For further information please contact:
Advertising David Hirsh Nick Matthews	Editorial Rupert Gilbey

View the digital version of ICT

	Subscribe
	Current Issue
	Archives
	Media Info
	Our Clients

Featured in this issue

DRUG DISCOVERY & DELIVERY
Rare Diseases

Changing Lives

With more rare diseases being discovered each year, a dramatic rise in orphan drug development is taking place. Rani Abraham and Rabinder Buttar of ClinTec International predict the trial potential of the Middle East and North Africa as the industry plays catch up.

Interview
Industry Interview

Thinking Allowed

Myoderm’s Michael Cohen talks to ICT about the surge in demand for comparator drugs, and the big sourcing and supply issues ahead.

eCLINICAL

Investigator Site Files

Electronic Edge

As the industry continues to go electronic, paper-based investigator site files are inevitably giving way to eISFs. Phlexglobal’s Gillian Gittens argues that the process and compliance improvements are significant, but so too are the obstacles to implementation.

Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August and November

Banner of Thomson Reuters.ICT on Samedan

Industry Events

Advances and Progress in Drug Design

17-18 February 2014, Marriott Regents Park Hotel, London, UK

SMi are proud to present the 13th annual Advances and Progress in Drug Design conference, convening in Central London on Monday 17 and Tuesday 18 February 2014. This exciting event will focus on new approaches and will offer attendees the chance to hear from leading industry experts on lead optimisation strategies, SBDD and FBDD.
More info >>

All events >>

News and Press Releases

Taconic and Medicyte Announce Strategic Marketing Alliance

New York, USA and Heidelberg, Germany, September 4, 2013 – Taconic and Medicyte today announced the formation of a marketing and sales agreement through which Taconic will promote and sell human primary upycte® hepatocyte cell strains and corresponding media developed by Medicyte for in vitro applications. The agreement effective immediately strengthens Taconic’s tADMET™ portfolio of models and provides Medicyte broader distribution of its products as well as increased market visibility and entrance into new markets for its hepatocyte cell strains.
More info >>

All releases >>

Air Transport Publications

White Papers

Convergence in the Pharmaceutical Market

Packaging Coordinators, Inc.

Convergence is currently playing a large part in the growth of the pharmaceutical market. The need for convergence is due to many factors including the declining economy and high competition within the sector. There are many convergences within this sector to date; these include the convergence of food based products with medical and health products and the convergence of prescription drugs to over the counter (OTC) products. Although convergence is helping the pharmaceutical industry expand and develop, it also poses some challenges; these include the regulatory outlook and counterfeiting.
More info >>

All white papers >>